116 related articles for article (PubMed ID: 29678583)
1. Identifying the SUMO1 modification of FAM122A leading to the degradation of PP2A-Cα by ubiquitin-proteasome system.
Fan F; Zhao J; Liu Y; Zhao H; Weng L; Li Q; Chen G; Xu Y
Biochem Biophys Res Commun; 2018 Jun; 500(3):676-681. PubMed ID: 29678583
[TBL] [Abstract][Full Text] [Related]
2. FAM122A, a new endogenous inhibitor of protein phosphatase 2A.
Fan L; Liu MH; Guo M; Hu CX; Yan ZW; Chen J; Chen GQ; Huang Y
Oncotarget; 2016 Sep; 7(39):63887-63900. PubMed ID: 27588481
[TBL] [Abstract][Full Text] [Related]
3. Functional Crosstalk between the PP2A and SUMO Pathways Revealed by Analysis of STUbL Suppressor, razor 1-1.
Nie M; Arner E; Prudden J; Schaffer L; Head S; Boddy MN
PLoS Genet; 2016 Jul; 12(7):e1006165. PubMed ID: 27398807
[TBL] [Abstract][Full Text] [Related]
4. SUMO protease SENP1 deSUMOylates and stabilizes c-Myc.
Sun XX; Chen Y; Su Y; Wang X; Chauhan KM; Liang J; Daniel CJ; Sears RC; Dai MS
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):10983-10988. PubMed ID: 30305424
[TBL] [Abstract][Full Text] [Related]
5. Sumoylation as a signal for polyubiquitylation and proteasomal degradation.
Miteva M; Keusekotten K; Hofmann K; Praefcke GJ; Dohmen RJ
Subcell Biochem; 2010; 54():195-214. PubMed ID: 21222284
[TBL] [Abstract][Full Text] [Related]
6. SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination.
Luo HB; Xia YY; Shu XJ; Liu ZC; Feng Y; Liu XH; Yu G; Yin G; Xiong YS; Zeng K; Jiang J; Ye K; Wang XC; Wang JZ
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16586-91. PubMed ID: 25378699
[TBL] [Abstract][Full Text] [Related]
7. The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle.
Schimmel J; Larsen KM; Matic I; van Hagen M; Cox J; Mann M; Andersen JS; Vertegaal AC
Mol Cell Proteomics; 2008 Nov; 7(11):2107-22. PubMed ID: 18565875
[TBL] [Abstract][Full Text] [Related]
8. Protein Phosphatase Methyl-Esterase PME-1 Protects Protein Phosphatase 2A from Ubiquitin/Proteasome Degradation.
Yabe R; Miura A; Usui T; Mudrak I; Ogris E; Ohama T; Sato K
PLoS One; 2015; 10(12):e0145226. PubMed ID: 26678046
[TBL] [Abstract][Full Text] [Related]
9. Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor.
Tirard M; Almeida OF; Hutzler P; Melchior F; Michaelidis TM
Mol Cell Endocrinol; 2007 Mar; 268(1-2):20-9. PubMed ID: 17314004
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the tumor suppressor PTEN by SUMO.
González-Santamaría J; Campagna M; Ortega-Molina A; Marcos-Villar L; de la Cruz-Herrera CF; González D; Gallego P; Lopitz-Otsoa F; Esteban M; Rodríguez MS; Serrano M; Rivas C
Cell Death Dis; 2012 Sep; 3(9):e393. PubMed ID: 23013792
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the SUMO1 and ubiquitin conjugation pathways during the inhibition of proteasome activity with evidence of SUMO1 recycling.
Bailey D; O'Hare P
Biochem J; 2005 Dec; 392(Pt 2):271-81. PubMed ID: 16117725
[TBL] [Abstract][Full Text] [Related]
12. SUMO modification of Akt regulates global SUMOylation and substrate SUMOylation specificity through Akt phosphorylation of Ubc9 and SUMO1.
Lin CH; Liu SY; Lee EH
Oncogene; 2016 Feb; 35(5):595-607. PubMed ID: 25867063
[TBL] [Abstract][Full Text] [Related]
13. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
Citro S; Chiocca S
Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
[TBL] [Abstract][Full Text] [Related]
14. Uncovering the SUMOylation and ubiquitylation crosstalk in human cells using sequential peptide immunopurification.
Lamoliatte F; McManus FP; Maarifi G; Chelbi-Alix MK; Thibault P
Nat Commun; 2017 Jan; 8():14109. PubMed ID: 28098164
[TBL] [Abstract][Full Text] [Related]
15. CHFR is negatively regulated by SUMOylation-mediated ubiquitylation.
Bae SJ; Kwon YE; Kim M; Seol JH
Biochem Biophys Res Commun; 2013 Apr; 433(2):194-9. PubMed ID: 23454125
[TBL] [Abstract][Full Text] [Related]
16. Non-canonical ubiquitin-based signals for proteasomal degradation.
Kravtsova-Ivantsiv Y; Ciechanover A
J Cell Sci; 2012 Feb; 125(Pt 3):539-48. PubMed ID: 22389393
[TBL] [Abstract][Full Text] [Related]
17. SUMOylation of Blimp-1 promotes its proteasomal degradation.
Shimshon L; Michaeli A; Hadar R; Nutt SL; David Y; Navon A; Waisman A; Tirosh B
FEBS Lett; 2011 Aug; 585(15):2405-9. PubMed ID: 21722636
[TBL] [Abstract][Full Text] [Related]
18. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation.
Tatham MH; Geoffroy MC; Shen L; Plechanovova A; Hattersley N; Jaffray EG; Palvimo JJ; Hay RT
Nat Cell Biol; 2008 May; 10(5):538-46. PubMed ID: 18408734
[TBL] [Abstract][Full Text] [Related]
19. SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7.
Janer A; Werner A; Takahashi-Fujigasaki J; Daret A; Fujigasaki H; Takada K; Duyckaerts C; Brice A; Dejean A; Sittler A
Hum Mol Genet; 2010 Jan; 19(1):181-95. PubMed ID: 19843541
[TBL] [Abstract][Full Text] [Related]
20. Post-translational modification of POU domain transcription factor Oct-4 by SUMO-1.
Zhang Z; Liao B; Xu M; Jin Y
FASEB J; 2007 Oct; 21(12):3042-51. PubMed ID: 17496161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
